Fortress Biotech FBIO
NASDAQ FBIO
$1.99 +0.05 (+2.45%)
As of: Oct 22, 2026 · 10:40 AM EDT

Fortress Biotech (FBIO) Convertible Debt (2021)

Updated

Fortress Biotech (FBIO) reported Convertible Debt of $18.08 million for Q3 2021, up 44.5% from the prior quarter.

Analysis

Fortress Biotech (FBIO) Convertible Debt (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,162.99 Bn 1,131.58 Bn 19.71 Bn
2 Johnson & Johnson 633.71 Bn 552.23 Bn 17.26 Bn
3 AbbVie 502.40 Bn 475.51 Bn 12.70 Bn
4 Merck 376.48 Bn 330.86 Bn 12.21 Bn
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn
6 Astrazeneca 267.02 Bn 240.70 Bn 12.86 Bn
7 Amgen 240.85 Bn 196.25 Bn 7.24 Bn
8 Gilead Sciences 193.39 Bn 167.58 Bn 6.22 Bn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn
10 Fortress Biotech 63.18 Mn -373.38 Mn 12.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 18.08 Mn
Jun 30, 2021 12.51 Mn
Mar 31, 2021 10.69 Mn
API Access

Fortress Biotech Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=FBIO&period=max&api_key=YOUR_API_KEY